Delivery Order SPE2DB20D1100-SPE2DB25FB0J0

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,036.46, is for the delivery of 4566518231 - LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has a ceiling value of $5,036.46 and runs through November 22, 2024. This award is part of...
This federal contract award, valued at $2,277.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,181.62 firm fixed-price delivery order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S medical products, with a period of performance through January 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,912.53 Firm Fixed Price Delivery Order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a contraceptive medication. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,470.08, is for the delivery of LO LOESTRIN FE 1-10 tablets over a period ending on February 20, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,333.84 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,613.57 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, with a completion date of May 29, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.41 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $3,909.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, with a final completion date of February 19, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,211.15, is a Firm Fixed Price Delivery Order for the supply of LOESTRIN FE 1-20 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB0J0
    Delivery Order

This federal contract award, valued at $1,650.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not designated with any set-aside requirements, indicating open competition.

Generated 6/9/25, 9:44 AM